Literature DB >> 29980797

Protective effect of pentoxifylline on oxidative renal cell injury associated with renal crystal formation in a hyperoxaluric rat model.

Hayrettin Ozturk1, Ayhan Cetinkaya2, Tulin Siviloglu Firat3, Buket Kin Tekce4, Selma Erdogan Duzcu5, Hulya Ozturk6.   

Abstract

The aim of the study is to investigate the effects of pentoxifylline (PTX) on the renal tubular cell injury and stone formation in a hyperoxaluric rat model induced by ethylene glycol and its possible underlying mechanisms. The study was performed with 30 male Wistar rats and randomized into three groups of teen. The sham-control (group 1) received only drinking water orally. The EG/untreated (group 2) received drinking water containing 0.75% EG for 4 weeks orally. The EG/PTX treated (group 3) received drinking water containing 0.75% EG for 4 weeks orally and PTX. Urine and blood were collected to determine some parameters. The kidneys were also removed for histological examination. Serum and urinary parameters were significantly improved in the EG/PTX treated. In the EG/PTX-treated group, the MDA, TOS and MPO activity reduced and the TAS, SOD, CAT and GSH-Px activities were increased markedly compared with the group 2. In urine of the group 2 rats, a large number of CaOx crystals were displayed and most tubules that contained crystals were dilated and showed degeneration, necrosis, and desquamation of the lining epithelium. Only few CaOx crystals were r in EG/PTX-treated animal's urine. Mild tissue damage was observed in PTX-treated rats. iNOS expression was significantly elevated in the group 2. In contrast, in the EG/PTX-treated group, eNOS expression in renal tubular epithelial cells was increased. Current study indicates that PTX may partially reduce renal tubular injury resulting from hyperoxaluria-induced oxidative and nitrosative stress.

Entities:  

Keywords:  Ethylene glycol; Experimental nephrocalcinosis; Oxidative stress; Pentoxifylline; Rat

Mesh:

Substances:

Year:  2018        PMID: 29980797     DOI: 10.1007/s00240-018-1072-8

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  53 in total

1.  Oxalate toxicity in renal epithelial cells: characteristics of apoptosis and necrosis.

Authors:  C Miller; L Kennington; R Cooney; Y Kohjimoto; L C Cao; T Honeyman; J Pullman; J Jonassen; C Scheid
Journal:  Toxicol Appl Pharmacol       Date:  2000-01-15       Impact factor: 4.219

Review 2.  Nitric oxide in acute renal failure: NOS versus NOS.

Authors:  Michael S Goligorsky; Sergey V Brodsky; Eisei Noiri
Journal:  Kidney Int       Date:  2002-03       Impact factor: 10.612

3.  Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants.

Authors:  Sivagnanam Thamilselvan; Saeed R Khan; Mani Menon
Journal:  Urol Res       Date:  2002-11-22

4.  Effect of A. lanata leaf extract and Vediuppu chunnam on the urinary risk factors of calcium oxalate urolithiasis during experimental hyperoxaluria.

Authors:  R Selvam; P Kalaiselvi; A Govindaraj; V Bala Murugan; A S Sathish Kumar
Journal:  Pharmacol Res       Date:  2001-01       Impact factor: 7.658

5.  Production of superoxide through NADH oxidase in thick ascending limb of Henle's loop in rat kidney.

Authors:  Ningjun Li; Fu-Xian Yi; Jamie L Spurrier; Carol A Bobrowitz; Ai-Ping Zou
Journal:  Am J Physiol Renal Physiol       Date:  2002-06

6.  Use of pentoxifylline in membranous nephropathy.

Authors:  D Ducloux; C Bresson-Vautrin; J Chalopin
Journal:  Lancet       Date:  2001-05-26       Impact factor: 79.321

7.  Identification of renox, an NAD(P)H oxidase in kidney.

Authors:  M Geiszt; J B Kopp; P Várnai; T L Leto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

8.  Pentoxifylline attenuated the renal disease progression in rats with remnant kidney.

Authors:  Shuei-Liong Lin; Yung-Ming Chen; Chiang-Ting Chien; Wen-Chih Chiang; Chien-Chen Tsai; Tun-Jun Tsai
Journal:  J Am Soc Nephrol       Date:  2002-12       Impact factor: 10.121

9.  Mitochondrial superoxide production during oxalate-mediated oxidative stress in renal epithelial cells.

Authors:  F D Khand; M P Gordge; W G Robertson; A A Noronha-Dutra; J S Hothersall
Journal:  Free Radic Biol Med       Date:  2002-06-15       Impact factor: 7.376

10.  Prophylaxis of calcium oxalate stones by Herniaria hirsuta on experimentally induced nephrolithiasis in rats.

Authors:  F Atmani; Y Slimani; M Mimouni; B Hacht
Journal:  BJU Int       Date:  2003-07       Impact factor: 5.588

View more
  5 in total

1.  Synergistic effect of berberine and pentoxifylline in attenuation of acute kidney injury.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; Nawar R Hussien
Journal:  Int J Crit Illn Inj Sci       Date:  2019 Apr-Jun

2.  Metabolomic analysis reveals a protective effect of Fu-Fang-Jin-Qian-Chao herbal granules on oxalate-induced kidney injury.

Authors:  Wei Chen; Wen-Rui Liu; Jie-Bin Hou; Jia-Rong Ding; Zhong-Jiang Peng; Song-Yan Gao; Xin Dong; Jun-Hua Ma; Qi-Shan Lin; Jian-Rao Lu; Zhi-Yong Guo
Journal:  Biosci Rep       Date:  2019-02-22       Impact factor: 3.840

3.  Protective Effect of Degraded Porphyra yezoensis Polysaccharides on the Oxidative Damage of Renal Epithelial Cells and on the Adhesion and Endocytosis of Nanocalcium Oxalate Crystals.

Authors:  Qian-Long Peng; Chuang-Ye Li; Yao-Wang Zhao; Xin-Yuan Sun; Hong Liu; Jian-Ming Ouyang
Journal:  Oxid Med Cell Longev       Date:  2021-03-03       Impact factor: 6.543

4.  Pentoxifylline mitigates cholestasis-related cholemic nephropathy.

Authors:  Mohammad Mehdi Ommati; Sara Hojatnezhad; Narges Abdoli; Ram Kumar Manthari; Zhipeng Jia; Asma Najibi; Amin Reza Akbarizadeh; Issa Sadeghian; Omid Farshad; Negar Azarpira; Hossein Niknahad; Reza Heidari
Journal:  Clin Exp Hepatol       Date:  2021-11-25

Review 5.  A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19.

Authors:  Gomaa Mostafa-Hedeab; Hayder M Al-Kuraishy; Ali I Al-Gareeb; Philippe Jeandet; Hebatallah M Saad; Gaber El-Saber Batiha
Journal:  Inflammopharmacology       Date:  2022-04-29       Impact factor: 5.093

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.